Nyheter/rapporter

Senaste pressmeddelanden och rapporter för bevakat bolag.

Datum Källa Rubrik Typ Alternativ
2024-04-25 Penser Access by Carnegie Penser Access by Carnegie: Senzime - Vinner mark i USA Pressreleaser Visa Stäng
2024-04-24 Senzime Senzime publishes annual and sustainability report for 2023 Rapporter Ladda ner | Visa Stäng
2024-04-24 Senzime SENZIME PUBLICERAR ÅRS- OCH HÅLLBARHETSREDOVISNING FÖR 2023 Rapporter Ladda ner | Visa Stäng
2024-04-24 Senzime Senzime Wins Another Major US Veterans Affairs contract; Expands Reach of TetraGraph System Pressreleaser Ladda ner | Visa Stäng
2024-04-24 Senzime Senzime vinner ytterligare en större offentlig upphandling från Veterans Health Administration i USA Pressreleaser Ladda ner | Visa Stäng
2024-04-17 Senzime Kallelse till årsstämma i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2024-04-17 Senzime Notice of Annual General Meeting in Senzime ab (PUBL) Pressreleaser Ladda ner | Visa Stäng
2024-04-10 Senzime From Kids to Robots: Senzime secures multiple top-rated US hospital deals Pressreleaser Ladda ner | Visa Stäng
2024-04-10 Senzime Från barn till robotar: Senzime säkrar kontrakt med flera ledande USA-sjukhus Pressreleaser Ladda ner | Visa Stäng
2024-04-09 Senzime Senzime: Biostock: Målet: Förändra världen för hundra miljoner | Health & Wealth #10 Pressreleaser Visa Stäng
2024-03-07 Senzime Senzime wins its largest US deal to date from leading Houston based university hospital system Pressreleaser Ladda ner | Visa Stäng
2024-03-07 Senzime Senzime säkrar sin hittills största USA-affär från ledande Houston-baserat sjukhussystem Pressreleaser Ladda ner | Visa Stäng
2024-02-19 Penser Access by Carnegie Penser Access by Carnegie: Senzime - Bra fart in i 2024 Pressreleaser Visa Stäng
2024-02-15 Penser Access by Carnegie Penser Access by Carnegie: Intervju med Senzime- Carnegie Investment Bank - 15 feb 2024 Pressreleaser Visa Stäng
2024-02-15 Senzime Senzime: Bokslutskommuniké januari – december 2023 Rapporter Ladda ner | Visa Stäng
2024-02-15 Senzime Senzime: Year-end report January – December 2023 Rapporter Ladda ner | Visa Stäng
2024-02-09 Senzime Invitation to Senzime’s fourth quarter 2023 report presentation Pressreleaser Ladda ner | Visa Stäng
2024-02-09 Senzime Inbjudan till presentation av Senzimes bokslutskommuniké 2023 Pressreleaser Ladda ner | Visa Stäng
2024-02-07 Senzime Senzimes licenstagare Fukuda Denshi lanserar integrerad TetraGraph-modul på den japanska marknaden Pressreleaser Ladda ner | Visa Stäng
2024-02-07 Senzime Senzime licensee Fukuda Denshi launches integrated TetraGraph module in Japanese market Pressreleaser Ladda ner | Visa Stäng
2024-01-17 Senzime Senzime expands its US commercial operations Pressreleaser Ladda ner | Visa Stäng
2024-01-17 Senzime Senzime expanderar kommersiella verksamheten i USA Pressreleaser Ladda ner | Visa Stäng
2023-12-21 Senzime Senzime säkrar TetraGraph-kontrakt från stort sjukhussystem i New York-regionen Pressreleaser Ladda ner | Visa Stäng
2023-12-21 Senzime Senzime secures initial TetraGraph order from major New York metropolitan region university hospital group Pressreleaser Ladda ner | Visa Stäng
2023-11-30 Senzime Förändrat antal aktier och röster i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-11-30 Senzime New number of shares and votes in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-11-30 Senzime Senzime secures multiple university hospital orders in Germany Pressreleaser Ladda ner | Visa Stäng
2023-11-30 Senzime Senzime säkrar ordrar från flera universitetssjukhus i Tyskland Pressreleaser Ladda ner | Visa Stäng
2023-11-28 Senzime Kommuniké från Extra Bolagsstämma i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-11-28 Senzime Bulletin from Extraordinary General Meeting in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-11-15 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Senzime AB (publ.) Pressreleaser Visa Stäng
2023-11-13 Senzime Utfall i riktad nyemission av aktier till säljare av Respiratory Motion Pressreleaser Ladda ner | Visa Stäng
2023-11-13 Senzime Outcome of directed share issue to sellers of Respiratory Motion Pressreleaser Ladda ner | Visa Stäng
2023-11-09 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Senzime AB (publ.) Pressreleaser Visa Stäng
2023-11-08 Senzime Senzime publishes prospectus relating to the directed share issue Pressreleaser Ladda ner | Visa Stäng
2023-11-08 Senzime Senzime offentliggör prospekt avseende den riktade emissionen Pressreleaser Ladda ner | Visa Stäng
2023-11-08 Senzime New study validates Senzime’s TetraGraph waveforms using an AI-based neural network Pressreleaser Ladda ner | Visa Stäng
2023-11-08 Senzime Ny studie validerar data från Senzimes TetraGraph med ett AI-baserat neuralt nätverk Pressreleaser Ladda ner | Visa Stäng
2023-11-07 Senzime Senzime emitterar en tredje tranche vederlagsaktier till säljare av Respiratory Motion Pressreleaser Ladda ner | Visa Stäng
2023-11-07 Senzime Senzime issues a third tranche of consideration shares to sellers of Respiratory Motion Pressreleaser Ladda ner | Visa Stäng
2023-11-03 Senzime Notice of Extraordinary General Meeting in Senzime AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-11-03 Senzime Kallelse till Extra Bolagsstämma i Senzime AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-10-27 Senzime Senzime-aktien börjar handlas på USA-baserade OTCQX-listan Pressreleaser Ladda ner | Visa Stäng
2023-10-27 Senzime Senzime shares begin trading on the US-based OTCQX Market Pressreleaser Ladda ner | Visa Stäng
2023-10-27 Penser Access Penser Access: Bra momentum - Senzime Pressreleaser Visa Stäng
2023-10-26 Penser Access Penser Access: Interview with Senzime - Erik Penser Bank - Oct 26th 2023 Pressreleaser Visa Stäng
2023-10-26 Senzime Senzime: Interim report January – September 2023 Rapporter Ladda ner | Visa Stäng
2023-10-26 Senzime Senzime: Delårsrapport januari – september 2023 Rapporter Ladda ner | Visa Stäng
2023-10-24 Senzime Senzime meddelar att den riktade emissionen om 117 MSEK har fulltecknats Pressreleaser Ladda ner | Visa Stäng
2023-10-24 Senzime Senzime announces full subscription of 117 MSEK directed share issue Pressreleaser Ladda ner | Visa Stäng
2023-10-23 Senzime Inbjudan till presentation av Senzimes rapport för tredje kvartalet 2023 Pressreleaser Ladda ner | Visa Stäng
2023-10-23 Senzime Invitation to Senzime’s third quarter 2023 report presentation Pressreleaser Ladda ner | Visa Stäng
2023-10-19 Senzime Kommuniké från EXTRA BOLAGSSTÄMMA i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-10-19 Senzime Bulletin from EXTRAORDINARY GENERAL MEETING in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-10-18 Senzime Senzime presenterar på BioStock Life Science Summit den 26 oktober Pressreleaser Visa Stäng
2023-10-13 Senzime Senzime secures contract with top-10 ranked, US East Coast-based university hospital system Pressreleaser Ladda ner | Visa Stäng
2023-10-13 Senzime Senzime tecknar kontrakt med topp 10-rankat amerikanskt universitetssjukhus i östra USA Pressreleaser Ladda ner | Visa Stäng
2023-10-09 Senzime Senzime lanserar TetraSensitive, marknadens första sensor för neuromuskulär övervakning av patienter med känslig hud Pressreleaser Ladda ner | Visa Stäng
2023-10-09 Senzime Senzime launches TetraSensitive, the market's first sensor for neuromuscular monitoring of patients with sensitive skin Pressreleaser Ladda ner | Visa Stäng
2023-09-29 Senzime New number of shares and votes in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-09-29 Senzime Förändrat antal aktier och röster i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-09-28 Penser Access Penser Access: Intervju med Senzime - Erik Penser Bank - 27 september 2023 Pressreleaser Visa Stäng
2023-09-27 Senzime KALLELSE TILL EXTRA BOLAGSSTÄMMA I SENZIME AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-09-27 Senzime NOTICE OF EXTRAORDINARY GENERAL MEETING IN SENZIME AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 27 Sep 2023 | Senzime

NOTICE OF EXTRAORDINARY GENERAL MEETING IN SENZIME AB (PUBL)

The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extraordinary general meeting on Thursday 19 October 2023 at 16.00 at Senzime AB’s premises on Ulls väg 41 in Uppsala.

Notice etc.

Shareholders who wish to participate in the general meeting must:

  • be registered in the share register kept by Euroclear Sweden AB on Wednesday 11 October 2023 (the record date), and
  • notify his or her intention to attend the general meeting to the Company no later than Monday 16 October 2023, by mail to Advokatfirman Lindahl KB, Att: Michaela Larsson, Box 1203, 751 42 Uppsala stating “general meeting” or by e-mail to michaela.larsson@lindahl.se .

Such notification shall include the shareholder’s name, personal identification number or corporate registration number, address and telephone number, number of shares, details on advisors (no more than two), if any, and, where applicable, details of representatives or proxies.

Nominee-registered shares

Shareholders whose shares are registered in the name of a nominee through a bank or other trustee must, in addition to notify his or her intention to attend the general meeting, register their shares in their own name so that the shareholder is included in the share register kept by Euroclear Sweden on 11 October 2023. Such registration may be temporary (so-called voting rights registration) and shall be requested by shareholders in such time and in accordance with the routines that the nominee determines. Voting rights registrations that have been completed by the nominee no later than 13 October 2023 will be considered in the preparation of the share register.

Proxy

Shareholders represented by proxy must submit a dated power of attorney. If the power of attorney is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The power of attorney may not be valid for a period exceeding five years from its issuance. The original power of attorney and certificate of registration should be submitted to the Company by mail at the address mentioned above in due time prior to the general meeting. Alternatively, the original power of attorney and certificate of registration may be brought and presented at the general meeting. The Company provides a power of attorney form at request and on the Company’s website, www.senzime.com .

Number of shares and votes

As of the date of this notice, there are a total of 98,985,114 shares and votes in the Company.

Proposed agenda

  1. Opening of the general meeting and election of chairman of the general meeting
  2. Preparation and approval of the voting list
  3. Election of one or two persons to verify the minutes
  4. Approval of the agenda
  5. Determination as to whether the meeting has been duly convened
  6. Resolution on the approval of the board of directors’ resolution on a directed share issue
  7. Closing of the general meeting

Proposals to resolutions

Item 1 – Election of chairman of the general meeting

The nomination committee proposes that Mattias Prage, lawyer at Advokatfirman Lindahl KB, is elected as chairman of the general meeting or, in his absence, the person otherwise appointed by the board of directors.

Item 6 – Resolution on the approval of the board of directors’ resolution on a directed share issue
On 25 September 2023 the board resolved, subject to approval by the general meeting, on a directed share issue on the terms and conditions set out below (in italics). The board proposes that the general meeting approves the board’s resolution.
Subject to approval by the extraordinary general meeting, the board of directors resolves to carry out a directed issue of maximum 18,000,000 new shares, entailing an increase in the share capital of maximum SEK 2,250,000.00. The resolution shall further be governed by the following terms and conditions.

  1. The right to subscribe for new shares shall, with deviation from the shareholders pre-emption rights, belong only to Nordic Issuing AB, for re-transfer to a limited number of investors pursuant to existing agreements.
  2. The reasons for deviating from the shareholders’ preferential rights are that the board of directors has assessed that it would not be doable to in a time- and cost-effective manner successfully carry out rights issue on terms favorable to the Company, at the same time as the Company is in need of capital. The board of directors considers it favorable for the Company and the shareholders to take advantage of the opportunity to inject new capital from strong and reputable investors on attractive terms and in a time and cost-effective manner. The board of directors’ overall assessment is that the reasons for carrying out the new share issue with deviation from the shareholders’ preferential rights overweigh the principal rule that new share issues shall be carried out with preferential rights for existing shareholders, and that a new issue with deviation from the shareholders’ preferential rights is therefore in the interest of Senzime and all its shareholders.
  3. Subscription of shares shall be made either by payment or on a subscription list not later than 20 October2023. The board of directors shall have the right to extend the subscription period.
  4. Payment for subscribed shares shall be made not later than 20 October 2023 (same date as the subscription). The board of directors shall have the right to extend the payment period.
  5. The new shares are issued at a price of SEK 0.125 per share, corresponding to the quota value for the Company’s share. However, the price to be used at re-transfer to investor shall correspond to SEK 6.50 per share. After re-transfer the Company will thus receive SEK 117,000,000(before transaction costs).
  6. The subscription price that will be applied at re-transfer to the investors is, according to board of director’s assessment, in line with market terms, since it is based on the current market price.
  7. The new shares entitle to dividends for the first time on the first record date for dividend that take place after the issue of new shares has been registered with the Swedish Companies Registration Office and been recorded in the share register kept by Euroclear Sweden AB.
  8. The Managing Director is entitled to make any minor changes necessary for the registration of the resolution with the Swedish Companies Registration Office and Euroclear Sweden AB.

Majority requirements

Resolutions in accordance with item 6 above requires, for its validity, a minimum of two-thirds (2/3) of both the votes cast and the shares represented at the general meeting.

Processing of personal data

For information regarding the processing of your personal data, please refer to https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf

The shareholders’ right to information at the general meeting

The board of directors and the CEO shall, up request by any shareholder, and where the board of directors deems that such information may be provided without significant harm to the Company, provide information in respect of any circumstances which may affect the assessment of a matter on the agenda or the Company’s financial position as well as the Company’s relationship to other group companies. Shareholders can submit questions in advance to the Company, to the address Ulls väg 41, Uppsala or through e-mail to Slavoljub.Grujicic@senzime.com .

Documents

Documents according to the Swedish Companies Act will be held available at the Company (Ulls väg 41, Uppsala) and at the Company’s website, www.senzime.com , no later than three weeks before the meeting, i.e., no later than 28 September 2023. The documents will also be sent, without charge, to shareholders who so request and inform the Company of their postal address.

Uppsala in September 2023
Senzime AB (publ)
The board of directors

2023-09-25 Senzime Senzime genomför riktad emission om 117 MSEK Pressreleaser Ladda ner | Visa Stäng
2023-09-25 Senzime Senzime carries out a directed share issue of MSEK 117 Pressreleaser Ladda ner | Visa Stäng
2023-09-22 Senzime Senzime meddelar att tidigare aviserad riktad emission nu fulltecknats Pressreleaser Ladda ner | Visa Stäng
2023-09-22 Senzime Senzime announces full subscription of directed share issue Pressreleaser Ladda ner | Visa Stäng
2023-09-20 Senzime Bulletin from extraordinary General meeting in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-09-20 Senzime Kommuniké från extra Bolagsstämma i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-09-18 Senzime Senzime säkrar ytterligare ett stort sjukhuskontrakt i USA Pressreleaser Ladda ner | Visa Stäng
2023-09-18 Senzime Senzime secures additional major US hospital contract Pressreleaser Ladda ner | Visa Stäng
2023-09-12 Senzime Senzime lämnar in ansökan om handel av bolagets aktie på OTCQX-marknaden i USA Pressreleaser Ladda ner | Visa Stäng
2023-09-12 Senzime Senzime has submitted application for cross-trading at OTCQX in the US Pressreleaser Ladda ner | Visa Stäng
2023-09-04 Penser Access Penser Access: Ökar takten - Senzime Pressreleaser Visa Stäng
2023-09-01 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Senzime AB (publ.) Pressreleaser Visa Stäng
2023-09-01 Senzime Senzime receives its largest order to date from top-10 ranked US hospital system Pressreleaser Ladda ner | Visa Stäng
2023-09-01 Senzime Senzime får sin största order hittills från topp 10-rankat amerikanskt sjukhussystem Pressreleaser Ladda ner | Visa Stäng
2023-08-31 Senzime Förändrat antal aktier och röster i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-08-31 Senzime New number of shares and votes in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-08-29 Senzime KALLELSE TILL extra bolagsstämma I Senzime AB (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-08-29 Senzime NOTICE OF extraordinary GENERAL MEETING IN Senzime ab (PUBL) Pressreleaser Ladda ner | Visa Stäng
2023-08-28 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Senzime AB (publ.) Pressreleaser Visa Stäng
2023-08-24 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Senzime AB (publ.) Pressreleaser Visa Stäng
2023-08-24 Senzime Senzime genomför riktad emission om ca 56 MSEK till rådande marknadskurs Pressreleaser Ladda ner | Visa Stäng
2023-08-24 Senzime Senzime carries out a directed share issue of approx. MSEK 56 at current market price Pressreleaser Ladda ner | Visa Stäng
2023-08-24 Senzime Delårsrapport januari – juni 2023 Rapporter Ladda ner | Visa Stäng
2023-08-24 Senzime Interim report January – June 2023 Rapporter Ladda ner | Visa Stäng
2023-08-17 Senzime Invitation to Senzime’s second quarter 2023 report presentation Pressreleaser Ladda ner | Visa Stäng
2023-08-17 Senzime Inbjudan till presentation av Senzimes rapport för andra kvartalet 2023 Pressreleaser Ladda ner | Visa Stäng
2023-07-31 Senzime New number of shares and votes in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-07-31 Senzime Förändrat antal aktier och röster i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-07-20 Senzime Senzime får större order från ledande universitetssjukhus i Kalifornien Pressreleaser Ladda ner | Visa Stäng
2023-07-20 Senzime Senzime receives large order from leading California University Hospital System Pressreleaser Ladda ner | Visa Stäng
2023-07-14 Senzime Utfall i riktad nyemission av aktier till säljare av Respiratory Motion Pressreleaser Ladda ner | Visa Stäng
2023-07-14 Senzime Outcome of directed share issue to sellers of Respiratory Motion Pressreleaser Ladda ner | Visa Stäng
2023-07-05 Senzime Senzime issues a second tranche of consideration shares to sellers of Respiratory Motion and extends the end date for the sellers to fulfil conditions to receive shares Pressreleaser Ladda ner | Visa Stäng
2023-07-05 Senzime Senzime emitterar en andra tranche vederlagsaktier till säljare av Respiratory Motion och förlänger slutdatumet för säljarnas uppfyllande av villkor för erhållande av aktier Pressreleaser Ladda ner | Visa Stäng
2023-07-03 Senzime New US study confirms the clinical advantage of the TetraGraph system for infants and young children Pressreleaser Ladda ner | Visa Stäng
2023-07-03 Senzime Ny amerikansk studie bekräftar kliniska fördelar med TetraGraph-systemet för små barn Pressreleaser Ladda ner | Visa Stäng
2023-07-03 Senzime Senzime ökar produktionskapaciteten baserat på ökad efterfrågan och upprop från europeiska och amerikanska anestesiföreningar Pressreleaser Ladda ner | Visa Stäng
2023-07-03 Senzime Senzime expands production capacity based on joint call from European and American Anesthesia Associations and increasing market demand Pressreleaser Ladda ner | Visa Stäng
2023-06-30 Senzime Senzime granted European patent for TetraSens Pressreleaser Ladda ner | Visa Stäng
2023-06-30 Senzime Senzime erhåller europeiskt patent för TetraSens Pressreleaser Ladda ner | Visa Stäng
2023-06-19 Senzime Senzime outlicenses ExSpiron in the Chinese market Pressreleaser Ladda ner | Visa Stäng
2023-06-19 Senzime Senzime utlicensierar ExSpiron för den kinesiska marknaden Pressreleaser Ladda ner | Visa Stäng
2023-06-05 Senzime Scientific study presented at Euroanaesthesia 2023 validates new TetraGraph algorithm Pressreleaser Ladda ner | Visa Stäng
2023-06-05 Senzime Presentation på Euroanaesthesia 2023 bekräftar kvaliteten i TetraGraphs nya algoritm Pressreleaser Ladda ner | Visa Stäng
2023-06-02 Senzime Senzime Capital Markets Update: Fokus på tillväxt och målen står fast Pressreleaser Ladda ner | Visa Stäng
2023-06-02 Senzime Senzime Capital Markets Update: Focus on growth and targets remain firm Pressreleaser Ladda ner | Visa Stäng
2023-05-30 Senzime Senzime expands partnership with Japanese licensee and starts system deliveries Pressreleaser Ladda ner | Visa Stäng
2023-05-30 Senzime Senzime utökar samarbetet med japansk licenstagare och inleder systemleveranser Pressreleaser Ladda ner | Visa Stäng
2023-05-29 Senzime Senzime bjuder in till Capital Markets Update Pressreleaser Ladda ner | Visa Stäng
2023-05-22 Penser Access Penser Access: Intervju med Senzime - Erik Penser Bank - 22 maj 2023 Pressreleaser Visa Stäng
2023-05-16 Senzime Kommuniké från årsstämma i Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-05-16 Senzime Bulletin from annual general meeting in Senzime AB (publ) Pressreleaser Ladda ner | Visa Stäng
2023-05-05 Senzime Senzimes valberedning reviderar förslag till beslut vid årsstämman Pressreleaser Ladda ner | Visa Stäng
2023-05-05 Senzime Senzime’s nomination committee adjusts its proposal for resolutions at the annual general meeting Pressreleaser Ladda ner | Visa Stäng
2023-05-04 Penser Access Penser Access: Ledningsbyte efter en stark start på året - Senzime Pressreleaser Visa Stäng
2023-05-03 Senzime Ny VD på Senzime Pressreleaser Ladda ner | Visa Stäng
2023-05-03 Senzime New CEO of Senzime Pressreleaser Ladda ner | Visa Stäng
2023-04-28 Penser Access Penser Access: Intervju med Senzime - Erik Penser Bank - 28 april 2023 Pressreleaser Visa Stäng
2023-04-28 Senzime Interim report January-March 2023 Rapporter Ladda ner | Visa Stäng
2023-04-28 Senzime Delårsrapport januari –mars 2023 Rapporter Ladda ner | Visa Stäng
2023-04-26 Senzime Senzime lanserar anslutning till plattformen Masimo Hospital Automation™ Pressreleaser Ladda ner | Visa Stäng
2023-04-26 Senzime Senzime announces connectivity with the Masimo Hospital Automation™ platform Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

7 May 2024 | Kvartalsrapport 2024-Q1
16 May 2024 | Årsstämma 2023
17 May 2024 | Årligutdelning
26 Aug 2024 | Kvartalsrapport 2024-Q2
6 Nov 2024 | Kvartalsrapport 2024-Q3